ウェスタンブロッティング市場：製品別（消耗品（抗体）、装置（電気泳動、ブロッティングシステム、イメージャー（蛍光））、用途別（バイオメディカル、臨床診断）、エンドユーザー別（研究機関、病院、バイオファーマ） - 2026年までの世界予測

Western Blotting Market by Product, (Consumables (Antibody), Instrument (Electrophoresis, Blotting System, Imager (Fluorescent))), Application (Biomedical, Clinical Diagnostics), End User (Research Institute, Hospital, Biopharma) - Global Forecast to 2026

ウェスタンブロッティングの世界市場は、2021年の10億米ドルから2026年には14億米ドルに達すると予測され、予測期間中のCAGRは6.7%となっています。技術の進歩、生物医学研究分野における政府の資金援助の増加、... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2021年11月16日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	263	350	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

ウェスタンブロッティングの世界市場は、2021年の10億米ドルから2026年には14億米ドルに達すると予測され、予測期間中のCAGRは6.7%となっています。技術の進歩、生物医学研究分野における政府の資金援助の増加、個別化医療への需要の高まり、HIVの有病率の上昇などが市場成長の主な要因です。

"機器セグメント別では、イメージャーサブセグメントがウェスタンブロッティング市場の急成長セグメントを占めています。"
ウェスタンブロッティング市場は、機器に基づいて、ゲル電気泳動機器、ブロッティングシステム、およびイメージャーに分類されます。この製品セグメントの成長は、主にイメージャーの自動化によってタンパク質の検出プロセスが簡素化されたことによるものです。

"エンドユーザーセグメント別では、学術・研究機関セグメントがウェスタンブロッティング市場の最大のシェアを占めています。"
ウェスタンブロッティング市場は、エンドユーザーに基づいて、学術・研究機関、バイオ医薬品・バイオテクノロジー企業、病院・診断ラボ、その他のエンドユーザーに分類されます 2020年には、学術・研究機関がウェスタンブロッティング市場で最大のシェアを占めました。学術・研究機関のエンドユーザーセグメントのシェアが大きいのは、政府による研究活動への投資が拡大していることや、プロテオミクス分野の研究が活発化していることが要因と考えられます。

"アジア太平洋地域。ウェスタンブロッティング市場で最も急成長している地域。"
アジア太平洋地域のウェスタンブロッティング市場は、予測期間中に最も高い成長を遂げると予測されています。アジア太平洋地域の市場成長を促進する主な要因としては、製薬・バイオテクノロジー産業の成長に対する政府の強力な支援、中国やインドにおけるバイオクラスターの存在、ライフサイエンス研究への資金提供の増加、標的疾患診断に関連するイニシアチブの拡大などが挙げられます。

"北米：ウェスタンブロッティング市場で最大のシェア"
2020年、北米はウェスタンブロッティング市場で最大のシェアを占めました。この地域の市場成長を促進する主な要因としては、この地域にウエスタンブロッティング製品のトップメーカーが存在すること、研究資金の増加、プロテオミクス研究への投資の増加、個別化医療への注目の高まりなどが挙げられます。

プライマリーの内訳

本調査では、部品メーカーからTier1企業、OEMまで、さまざまな業界の専門家による知見が得られています。プライマリーの内訳は以下の通りです。

- 回答者別-供給側：70%、需要側：30
- 回答者の属性：サプライサイド70％、デマンドサイド30％、CXOおよびディレクター30％、エグゼクティブ25％、マネジャー45％。
- 地域別では、北米40％、欧州25％、APAC20％、LATAM10％、MEA5％。

ウェスタンブロッティング市場の著名プレイヤーには、Bio-Rad Laboratories, Inc.(米国)、Thermo Fisher Scientific Inc.(米国)、Danaher Corporation(米国)、Merck KGaA(ドイツ)、Bio-Techne Corporation(米国)、PerkinElmer, Inc.(米国)、LI-COR, Inc.(米国)、Advansta Inc.(米国)、Cell Signaling Technology, Inc.(米国)、F. Hoffmann-La Roche Ltd. (スイス)、Azure Biosystems (米国)(スイス)、Azure Biosystems, Inc.(米国)、Boster Biological Technology (米国)、Geno Technology Inc.(米国)、Rockland Immunochemicals, Inc.(米国）、Precision Biosystems（米国）、Cleaver Scientific Ltd. （英国）、Abcam Plc.(英国）、Abcam Plc（英国）、Proteintech Group（米国）、Enzo Biochem, Inc.(米国)、Abnova Corporation(台湾)、Sino Biological Inc.(中国)、StressMarq Biosciences Inc.(カナダ）、Abbexa Ltd.(英国）、Covalab S.A.S. （フランス）、Biorbyt Ltd. （英国）。(英国)があります。

リサーチカバレッジ
当レポートでは、ウェスタンブロッティング市場を、地域（アジア太平洋地域、欧州、北米、中南米、中東・アフリカ）、製品（消耗品［試薬・バッファー、抗体・コンジュゲート｛一次抗体、二次抗体、その他の抗体・コンジュゲート｝、キット］、膜・濾紙、その他の消耗品）に基づいて分類しています。
膜・濾紙その他の消耗品]、機器[電気泳動、ブロッティングシステム{セミドライブロッティングシステム、ウェットブロッティングシステム}、イメージャー{化学発光イメージャー、蛍光イメージャー、その他のイメージャー}]）、アプリケーション（バイオメディカルリサーチ。臨床診断[HIV, Lyme Disease, Hepatitis, Other Diseases]、農業用途、その他の用途）、エンドユーザー（学術・研究機関、バイオ医薬品・バイオテクノロジー企業、病院・診断研究所、その他のエンドユーザー）を対象としています。また、ウエスタンブロッティング市場の市場促進要因、阻害要因機会、課題、トレンドについても包括的にまとめています。

このレポートを購入する主なメリット

本レポートは、この市場のリーダー/新規参入者が、市場全体およびサブセグメントの収益数値の最も近い近似値に関する情報を得るのに役立ちます。本レポートは、ステークホルダーが競争状況を理解し、ビジネスをより良く位置づけ、適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、本レポートは、ステークホルダーがウェスタンブロッティング市場の脈動を理解するのに役立ち、主要な市場ドライバー、阻害要因、課題、機会に関する情報を提供します。

ページTOPに戻る

1 INTRODUCTION 41
1.1 OBJECTIVES OF THE STUDY 41
1.2 MARKET DEFINITION 42
1.2.1 INCLUSIONS & EXCLUSIONS 42
1.3 MARKET SCOPE 43
1.3.1 MARKETS COVERED 43
FIGURE 1 WESTERN BLOTTING MARKET SEGMENTATION 43
1.3.2 YEARS CONSIDERED FOR THE STUDY 43
1.4 CURRENCY 44
1.5 LIMITATIONS 44
1.6 STAKEHOLDERS 44
1.7 SUMMARY OF CHANGES 45
2 RESEARCH METHODOLOGY 46
2.1 RESEARCH DATA 46
FIGURE 2 RESEARCH DESIGN 46
2.1.1 SECONDARY DATA 46
2.1.2 PRIMARY DATA 47
FIGURE 3 PRIMARY SOURCES 48
FIGURE 4 WESTERN BLOTTING MARKET: BREAKDOWN OF PRIMARIES 48
2.1.2.1 Key industry insights 49
2.2 MARKET SIZE ESTIMATION 50
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020 50
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP (SUPPLY SIDE) – COLLECTIVE REVENUE OF ALL WESTERN BLOTTING PRODUCTS 50
FIGURE 7 WESTERN BLOTTING MARKET: CAGR PROJECTIONS, 2021–2026 52
FIGURE 8 WESTERN BLOTTING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS OPPORTUNITIES, AND CHALLENGES 52
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 54
FIGURE 9 DATA TRIANGULATION METHODOLOGY 54
2.4 RESEARCH LIMITATIONS 55
2.5 GROWTH RATE ASSUMPTIONS 55
2.6 RISK ANALYSIS 56
3 EXECUTIVE SUMMARY 57
FIGURE 10 WESTERN BLOTTING MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 57
FIGURE 11 WESTERN BLOTTING MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 58
FIGURE 12 WESTERN BLOTTING MARKET SHARE, BY END USER, 2020 58
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE WESTERN BLOTTING MARKET 59
4 PREMIUM INSIGHTS 60
4.1 WESTERN BLOTTING MARKET OVERVIEW 60
FIGURE 14 TECHNOLOGICAL ADVANCEMENTS AND GROWING DEMAND FOR PERSONALIZED MEDICINE ARE KEY FACTORS DRIVING GROWTH IN
THE WESTERN BLOTTING MARKET 60
4.2 ASIA PACIFIC: WESTERN BLOTTING MARKET, BY END USER & COUNTRY (2020) 61
FIGURE 15 ACADEMIC & RESEARCH INSTITUTES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2020 61
4.3 WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2020 61
FIGURE 16 THE BLOTTING SYSTEMS SEGMENT DOMINATED THE MARKET IN 2020 61
4.4 WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2020 62
FIGURE 17 THE SEMI-DRY BLOTTING SYSTEMS SEGMENT IS PROJECTED TO WITNESS
THE HIGHEST GROWTH DURING THE FORECAST PERIOD 62
4.5 WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2020 62
FIGURE 18 THE CHEMILUMINESCENT IMAGERS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE WESTERN BLOTTING MARKET IN 2020 62
5 MARKET OVERVIEW 63
5.1 INTRODUCTION 63
5.2 MARKET DYNAMICS 63
FIGURE 19 WESTERN BLOTTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 63
5.2.1 DRIVERS 64
5.2.1.1 Technological advancements 64
5.2.1.2 Increasing government funding in the field of biomedical research 64
5.2.1.3 Growing demand for personalized medicine 65
FIGURE 20 NUMBER OF PERSONALIZED MEDICINES IN THE MARKET, 2008–2020 65
5.2.1.4 Rising global prevalence and incidence of HIV/AIDS 66
TABLE 1 INCIDENCE OF HIV/AIDS, BY REGION, 2020 66
5.2.2 RESTRAINTS 67
5.2.2.1 Emergence of alternative technologies 67
5.2.3 OPPORTUNITIES 67
5.2.3.1 Emerging economies 67
5.2.4 CHALLENGES 68
5.2.4.1 Requirement of high procedural efficiency for accurate results 68
5.3 IMPACT OF COVID-19 ON THE WESTERN BLOTTING MARKET 69
5.4 PATENT ANALYSIS 70
5.4.1 NUMBER OF PUBLICATIONS OVER THE LAST 10 YEARS 70
5.4.2 TOP 10 GRANTED PATENT OWNERS IN THE LAST 20 YEARS 70
5.4.3 TOP 10 PLAYERS WITH THE HIGHEST NO. OF PATENT APPLICATIONS 71
5.4.4 LIST OF RECENT PATENTS 71
5.5 REGULATORY GUIDELINES 72
5.5.1 NORTH AMERICA 72
5.5.2 EUROPE 72
5.5.3 EMERGING MARKETS 72
5.6 VALUE CHAIN ANALYSIS 73
FIGURE 21 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES 73
5.7 SUPPLY CHAIN ANALYSIS 74
FIGURE 22 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY FOR PROMINENT COMPANIES 75
5.8 PORTER’S FIVE FORCES ANALYSIS 75
TABLE 2 WESTERN BLOTTING MARKET: PORTER’S FIVE FORCES ANALYSIS 75
5.8.1 DEGREE OF COMPETITION 75
5.8.2 BARGAINING POWER OF SUPPLIERS 76
5.8.3 BARGAINING POWER OF BUYERS 76
5.8.4 THREAT FROM SUBSTITUTES 76
5.8.5 THREAT FROM NEW ENTRANTS 76
5.9 ECOSYSTEM ANALYSIS OF THE WESTERN BLOTTING MARKET 77
FIGURE 23 ECOSYSTEM ANALYSIS OF THE WESTERN BLOTTING MARKET 77
5.9.1 ROLE IN THE ECOSYSTEM 77
5.10 TECHNOLOGY ANALYSIS 78
5.10.1 ALTERNATIVES TO TRADITIONAL WESTERN BLOTTING 78
5.11 RANGES/SCENARIOS 79
FIGURE 24 DEPENDING ON HOW THE UNCERTAINTIES UNFOLD, WE SEE A SPECTRUM OF SCENARIOS FOR THE WESTERN BLOTTING MARKET 79
5.12 TRADE ANALYSIS 80
5.12.1 TRADE ANALYSIS FOR WESTERN BLOTTING 80
TABLE 3 IMPORT DATA FOR HS CODE 90278090, BY COUNTRY,
2016–2020 (USD MILLION) 80
TABLE 4 EXPORT DATA FOR HS CODE 90278090, BY COUNTRY,
2016–2020 (USD MILLION) 80
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 81
6 WESTERN BLOTTING MARKET, BY PRODUCT 82
6.1 INTRODUCTION 83
TABLE 5 WESTERN BLOTTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 83
6.2 CONSUMABLES 83
TABLE 6 WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 83
TABLE 7 WESTERN BLOTTING CONSUMABLES MARKET, BY REGION,
2019–2026 (USD MILLION) 84
TABLE 8 NORTH AMERICA: WESTERN BLOTTING CONSUMABLES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 84
TABLE 9 EUROPE: WESTERN BLOTTING CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 84
TABLE 10 APAC: WESTERN BLOTTING CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 85
6.2.1 REAGENTS & BUFFERS 85
6.2.1.1 High consumption of reagents & buffers during the western blot process to drive market growth 85
TABLE 11 WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS, BY REGION, 2019–2026 (USD MILLION) 86
TABLE 12 NORTH AMERICA: WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS, BY COUNTRY, 2019–2026 (USD MILLION) 86
TABLE 13 EUROPE: WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS,
BY COUNTRY, 2019–2026 (USD MILLION) 87
TABLE 14 APAC: WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS,
BY COUNTRY, 2019–2026 (USD MILLION) 87
6.2.2 ANTIBODIES & CONJUGATES 87
TABLE 15 WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 87
TABLE 16 WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES, BY REGION, 2019–2026 (USD MILLION) 88
TABLE 17 NORTH AMERICA: WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES, BY COUNTRY, 2019–2026 (USD MILLION) 88
TABLE 18 EUROPE: WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES,
BY COUNTRY, 2019–2026 (USD MILLION) 88
TABLE 19 APAC: WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES,
BY COUNTRY, 2019–2026 (USD MILLION) 89
6.2.2.1 Primary antibodies 89
6.2.2.1.1 Primary antibodies are mainly used to recognize a specific protein of interest 89
TABLE 20 WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES, BY REGION,
2019–2026 (USD MILLION) 89
TABLE 21 NORTH AMERICA: WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES, BY COUNTRY, 2019–2026 (USD MILLION) 90
TABLE 22 EUROPE: WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES,
BY COUNTRY, 2019–2026 (USD MILLION) 90
TABLE 23 APAC: WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES,
BY COUNTRY, 2019–2026 (USD MILLION) 90
6.2.2.2 Secondary antibodies 91
6.2.2.2.1 High sensitivity of secondary antibodies makes it easier to detect proteins of interest in complex protein mixtures 91
TABLE 24 WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES, BY REGION, 2019–2026 (USD MILLION) 91
TABLE 25 NORTH AMERICA: WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2019–2026 (USD MILLION) 91
TABLE 26 EUROPE: WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES,
BY COUNTRY, 2019–2026 (USD MILLION) 92
TABLE 27 APAC: WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES,
BY COUNTRY, 2019–2026 (USD MILLION) 92
6.2.2.3 Other antibodies & conjugates 92
TABLE 28 WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES,
BY REGION, 2019–2026 (USD MILLION) 93
TABLE 29 NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES, BY COUNTRY, 2019–2026 (USD MILLION) 93
TABLE 30 EUROPE: WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES, BY COUNTRY, 2019–2026 (USD MILLION) 93
TABLE 31 APAC: WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES, BY COUNTRY, 2019–2026 (USD MILLION) 94
6.2.3 KITS 94
6.2.3.1 Repeat purchases of single-use ready-to-use kits to drive market growth 94
TABLE 32 WESTERN BLOTTING MARKET FOR KITS, BY REGION,
2019–2026 (USD MILLION) 94
TABLE 33 NORTH AMERICA: WESTERN BLOTTING MARKET FOR KITS, BY COUNTRY, 2019–2026 (USD MILLION) 95
TABLE 34 EUROPE: WESTERN BLOTTING MARKET FOR KITS, BY COUNTRY,
2019–2026 (USD MILLION) 95
TABLE 35 APAC: WESTERN BLOTTING MARKET FOR KITS, BY COUNTRY,
2019–2026 (USD MILLION) 95
6.2.4 MEMBRANES & FILTER PAPERS 96
6.2.4.1 Extensive usage of membranes & filter papers to support the immobilization and transfer steps during western blotting experiments to drive market growth 96
TABLE 36 COMPARISON OF NITROCELLULOSE MEMBRANES AND PVDF MEMBRANES 96
TABLE 37 WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS,
BY REGION, 2019–2026 (USD MILLION) 97
TABLE 38 NORTH AMERICA: WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS, BY COUNTRY, 2019–2026 (USD MILLION) 97
TABLE 39 EUROPE: WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS, BY COUNTRY, 2019–2026 (USD MILLION) 97
TABLE 40 APAC: WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS,
BY COUNTRY, 2019–2026 (USD MILLION) 98
6.2.5 OTHER CONSUMABLES 98
TABLE 41 WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES, BY REGION, 2019–2026 (USD MILLION) 98
TABLE 42 NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2019–2026 (USD MILLION) 99
TABLE 43 EUROPE: WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES,
BY COUNTRY, 2019–2026 (USD MILLION) 99
TABLE 44 APAC: WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES,
BY COUNTRY, 2019–2026 (USD MILLION) 99
6.3 INSTRUMENTS 100
TABLE 45 WESTERN BLOTTING INSTRUMENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 100
TABLE 46 NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 100
TABLE 47 EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 101
TABLE 48 APAC: WESTERN BLOTTING INSTRUMENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 101
TABLE 49 WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 101

6.3.1 GEL ELECTROPHORESIS INSTRUMENTS 102
6.3.1.1 Increased demand for 2D electrophoresis due to its high separation performance is one of the major factors driving the growth of
the market 102
TABLE 50 WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY REGION, 2019–2026 (USD MILLION) 102
TABLE 51 NORTH AMERICA: WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION) 103
TABLE 52 EUROPE: WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION) 103
TABLE 53 APAC: WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION) 103
6.3.2 BLOTTING SYSTEMS 104
TABLE 54 COMPARISON BETWEEN PROTEIN BLOTTING SYSTEMS 104
TABLE 55 WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS, BY TYPE,
2019–2026 (USD MILLION) 104
TABLE 56 WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS, BY REGION,
2019–2026 (USD MILLION) 105
TABLE 57 NORTH AMERICA: WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION) 105
TABLE 58 EUROPE: WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION) 105
TABLE 59 APAC: WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION) 106
6.3.2.1 Wet blotting systems 106
6.3.2.1.1 Wet systems are most commonly used for the transfer of proteins from gels to membranes 106
TABLE 60 WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS, BY REGION, 2019–2026 (USD MILLION) 106
TABLE 61 NORTH AMERICA: WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION) 107
TABLE 62 EUROPE: WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION) 107
TABLE 63 APAC: WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION) 107
6.3.2.2 Semi-dry blotting systems 108
6.3.2.2.1 Minimal usage of buffers during the process and rapid transfer of proteins from gels to membranes are major factors driving the demand for semi-dry blotting systems 108
TABLE 64 WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS, BY REGION, 2019–2026 (USD MILLION) 108
TABLE 65 NORTH AMERICA: WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION) 108
TABLE 66 EUROPE: WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION) 109
TABLE 67 APAC: WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION) 109

6.3.3 IMAGERS 109
TABLE 68 WESTERN BLOTTING MARKET FOR IMAGERS, BY TYPE,
2019–2026 (USD MILLION) 110
TABLE 69 WESTERN BLOTTING MARKET FOR IMAGERS, BY REGION,
2019–2026 (USD MILLION) 110
TABLE 70 NORTH AMERICA: WESTERN BLOTTING MARKET FOR IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION) 110
TABLE 71 EUROPE: WESTERN BLOTTING MARKET FOR IMAGERS, BY COUNTRY,
2019–2026 (USD MILLION) 111
TABLE 72 APAC: WESTERN BLOTTING MARKET FOR IMAGERS, BY COUNTRY,
2019–2026 (USD MILLION) 111
6.3.3.1 Chemiluminescent imagers 111
6.3.3.1.1 Low cost of these imagers, easy handling, and sensitivity are some of the key factors contributing to the large share of this market 111
TABLE 73 WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS,
BY REGION, 2019–2026 (USD MILLION) 112
TABLE 74 NORTH AMERICA: WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION) 112
TABLE 75 EUROPE: WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION) 112
TABLE 76 APAC: WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS,
BY COUNTRY, 2019–2026 (USD MILLION) 113
6.3.3.2 Fluorescent imagers 113
6.3.3.2.1 Fluorescent imagers serve as one-stop imaging systems as they avoid multiple film exposures and development steps 113
TABLE 77 WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS, BY REGION, 2019–2026 (USD MILLION) 113
TABLE 78 NORTH AMERICA: WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION) 114
TABLE 79 EUROPE: WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS,
BY COUNTRY, 2019–2026 (USD MILLION) 114
TABLE 80 APAC: WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS,
BY COUNTRY, 2019–2026 (USD MILLION) 114
6.3.3.3 Other imagers 115
TABLE 81 WESTERN BLOTTING MARKET FOR OTHER IMAGERS, BY REGION,
2019–2026 (USD MILLION) 115
TABLE 82 NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER IMAGERS,
BY COUNTRY, 2019–2026 (USD MILLION) 115
TABLE 83 EUROPE: WESTERN BLOTTING MARKET FOR OTHER IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION) 116
TABLE 84 APAC: WESTERN BLOTTING MARKET FOR OTHER IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION) 116

7 WESTERN BLOTTING MARKET, BY APPLICATION 117
7.1 INTRODUCTION 118
TABLE 85 WESTERN BLOTTING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 118
7.2 BIOMEDICAL RESEARCH 118
7.2.1 INCREASING RESEARCH FUNDING FOR PROTEOMICS AND PROTEIN-BASED RESEARCH—A MAJOR DRIVER FOR THIS APPLICATION SEGMENT 118
TABLE 86 WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 119
TABLE 87 NORTH AMERICA: WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 119
TABLE 88 EUROPE: WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 119
TABLE 89 APAC: WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 120
7.3 CLINICAL DIAGNOSTICS 120
TABLE 90 WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS,
BY REGION, 2019–2026 (USD MILLION) 120
TABLE 91 NORTH AMERICA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 121
TABLE 92 EUROPE: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 121
TABLE 93 APAC: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 121
TABLE 94 WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS,
BY DISEASE TYPE, 2019–2026 (USD MILLION) 122
7.3.1 HIV 122
7.3.1.1 Western blotting is the most widely used method for HIV diagnosis—
a key factor driving market growth 122
TABLE 95 WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS, BY REGION,
2019–2026 (USD MILLION) 122
TABLE 96 NORTH AMERICA: WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION) 123
TABLE 97 EUROPE: WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS, BY COUNTRY, 2019–2026 (USD MILLION) 123
TABLE 98 APAC: WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS, BY COUNTRY, 2019–2026 (USD MILLION) 123
7.3.2 HEPATITIS 124
7.3.2.1 Growing incidence of hepatitis C to drive market growth 124
TABLE 99 WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS, BY REGION,
2019–2026 (USD MILLION) 124
TABLE 100 NORTH AMERICA: WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS, BY COUNTRY, 2019–2026 (USD MILLION) 124
TABLE 101 EUROPE: WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION) 125
TABLE 102 APAC: WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION) 125

7.3.3 LYME DISEASE 125
7.3.3.1 Western blots are generally considered the most reliable tests currently available for Lyme disease diagnosis 125
TABLE 103 WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS, BY REGION, 2019–2026 (USD MILLION) 126
TABLE 104 NORTH AMERICA: WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS, BY COUNTRY, 2019–2026 (USD MILLION) 126
TABLE 105 EUROPE: WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION) 126
TABLE 106 APAC: WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION) 127
7.3.4 OTHER DISEASES 127
TABLE 107 WESTERN BLOTTING MARKET FOR OTHER DISEASES, BY REGION,
2019–2026 (USD MILLION) 127
TABLE 108 NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER DISEASES,
BY COUNTRY, 2019–2026 (USD MILLION) 128
TABLE 109 EUROPE: WESTERN BLOTTING MARKET FOR OTHER DISEASES, BY COUNTRY, 2019–2026 (USD MILLION) 128
TABLE 110 APAC: WESTERN BLOTTING MARKET FOR OTHER DISEASES, BY COUNTRY, 2019–2026 (USD MILLION) 128
7.4 AGRICULTURAL APPLICATIONS 129
7.4.1 GROWING CULTIVATION OF GENETICALLY MODIFIED CROPS TO DRIVE MARKET GROWTH 129
TABLE 111 WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS,
BY REGION, 2019–2026 (USD MILLION) 129
TABLE 112 NORTH AMERICA: WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 129
TABLE 113 EUROPE: WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 130
TABLE 114 APAC: WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 130
7.5 OTHER APPLICATIONS 130
TABLE 115 WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS, BY REGION,
2019–2026 (USD MILLION) 131
TABLE 116 NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 131
TABLE 117 EUROPE: WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 131
TABLE 118 APAC: WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 132
8 WESTERN BLOTTING MARKET, BY END USER 133
8.1 INTRODUCTION 134
TABLE 119 WESTERN BLOTTING MARKET, BY END USER, 2019–2026 (USD MILLION) 134
8.2 ACADEMIC & RESEARCH INSTITUTES 134
8.2.1 INCREASING GOVERNMENT INVESTMENTS FOR RESEARCH ACTIVITIES TO DRIVE GROWTH IN THIS MARKET SEGMENT 134
TABLE 120 WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2019–2026 (USD MILLION) 135
TABLE 121 NORTH AMERICA: WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 135
TABLE 122 EUROPE: WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 135
TABLE 123 APAC: WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 136
8.3 BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 136
8.3.1 GROWING DRUG DISCOVERY AND CLINICAL STUDIES TO DRIVE THE DEMAND FOR WESTERN BLOTTING IN THE PHARMA-BIOTECH INDUSTRY 136
TABLE 124 WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION) 137
TABLE 125 NORTH AMERICA: WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 137
TABLE 126 EUROPE: WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 137
TABLE 127 APAC: WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 138
8.4 HOSPITALS & DIAGNOSTIC LABORATORIES 138
8.4.1 GROWING PATIENT POPULATION AND TESTING VOLUMES TO DRIVE MARKET GROWTH 138
TABLE 128 WESTERN BLOTTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2019–2026 (USD MILLION) 139
TABLE 129 NORTH AMERICA: WESTERN BLOTTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 139
TABLE 130 EUROPE: WESTERN BLOTTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 140
TABLE 131 APAC: WESTERN BLOTTING FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 140
8.5 OTHER END USERS 140
TABLE 132 WESTERN BLOTTING MARKET FOR OTHER END USERS, BY REGION,
2019–2026 (USD MILLION) 141
TABLE 133 NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER END USERS,
BY COUNTRY, 2019–2026 (USD MILLION) 141
TABLE 134 EUROPE: WESTERN BLOTTING MARKET FOR OTHER END USERS,
BY COUNTRY, 2019–2026 (USD MILLION) 141
TABLE 135 APAC: WESTERN BLOTTING MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 142
9 WESTERN BLOTTING MARKET, BY REGION 143
9.1 INTRODUCTION 144
9.2 NORTH AMERICA 144
FIGURE 25 NORTH AMERICA: WESTERN BLOTTING MARKET SNAPSHOT 144
TABLE 136 NORTH AMERICA: WESTERN BLOTTING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 145
TABLE 137 NORTH AMERICA: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 145
TABLE 138 NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 145
TABLE 139 NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 145
TABLE 140 NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION) 146
TABLE 141 NORTH AMERICA: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 146
TABLE 142 NORTH AMERICA: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 146
TABLE 143 NORTH AMERICA: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 147
TABLE 144 NORTH AMERICA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 147
TABLE 145 NORTH AMERICA: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 147
9.2.1 US 148
9.2.1.1 The US dominates the North American western blotting market 148
TABLE 146 US: WESTERN BLOTTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 148
TABLE 147 US: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 148 US: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 149 US: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 150 US: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 151 US: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 150
TABLE 152 US: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 150
TABLE 153 US: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 150
TABLE 154 US: WESTERN BLOTTING MARKET, BY END USER, 2019–2026 (USD MILLION) 151
9.2.2 CANADA 151
9.2.2.1 Strong infrastructure and availability of funding for biomedical research to support market growth in Canada 151
TABLE 155 CANADA: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 152
TABLE 156 CANADA: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 152
TABLE 157 CANADA: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 152
TABLE 158 CANADA: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS,
BY TYPE, 2019–2026 (USD MILLION) 152
TABLE 159 CANADA: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 160 CANADA: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 153
TABLE 161 CANADA: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 153
TABLE 162 CANADA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 154
TABLE 163 CANADA: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 154
9.3 EUROPE 154
TABLE 164 EUROPE: WESTERN BLOTTING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 155
TABLE 165 EUROPE: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 155
TABLE 166 EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 155
TABLE 167 EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 156
TABLE 168 EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS,
BY TYPE, 2019–2026 (USD MILLION) 156
TABLE 169 EUROPE: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 156
TABLE 170 EUROPE: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 171 EUROPE: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 157
TABLE 172 EUROPE: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 157
TABLE 173 EUROPE: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 158
9.3.1 GERMANY 158
9.3.1.1 Germany is the largest market for western blotting in Europe 158
TABLE 174 GERMANY: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 159
TABLE 175 GERMANY: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 176 GERMANY: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 159
TABLE 177 GERMANY: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 178 GERMANY: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 179 GERMANY: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 180 GERMANY: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 161
TABLE 181 GERMANY: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 161
TABLE 182 GERMANY: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 161

9.3.2 FRANCE 162
9.3.2.1 Proteomics research in France is strongly supported
by the government—a key factor driving market growth 162
TABLE 183 FRANCE: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 162
TABLE 184 FRANCE: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 185 FRANCE: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 186 FRANCE: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS,
BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 187 FRANCE: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 188 FRANCE: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 189 FRANCE: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 164
TABLE 190 FRANCE: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 165
TABLE 191 FRANCE: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 165
9.3.3 UK 165
9.3.3.1 Government support for disease diagnostics and the favorable investment scenario to drive the market in the UK 165
TABLE 192 UK: WESTERN BLOTTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 166
TABLE 193 UK: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 194 UK: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 195 UK: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 196 UK: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 197 UK: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 168
TABLE 198 UK: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 168
TABLE 199 UK: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 168
TABLE 200 UK: WESTERN BLOTTING MARKET, BY END USER, 2019–2026 (USD MILLION) 169
9.3.4 ITALY 169
9.3.4.1 Growth in this market is mainly driven by increasing life science R&D in the country 169
TABLE 201 ITALY: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 170
TABLE 202 ITALY: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 170
TABLE 203 ITALY: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 170
TABLE 204 ITALY: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 205 ITALY: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 171
TABLE 206 ITALY: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 207 ITALY: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 172
TABLE 208 ITALY: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 172
TABLE 209 ITALY: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 172
9.3.5 SPAIN 173
9.3.5.1 Well-established network for translational medicine research to drive market growth in Spain 173
TABLE 210 SPAIN: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 173
TABLE 211 SPAIN: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 174
TABLE 212 SPAIN: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 174
TABLE 213 SPAIN: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION) 174
TABLE 214 SPAIN: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 215 SPAIN: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 216 SPAIN: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 175
TABLE 217 SPAIN: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 176
TABLE 218 SPAIN: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 176
9.3.6 REST OF EUROPE (ROE) 176
TABLE 219 ROE: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 177
TABLE 220 ROE: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 177
TABLE 221 ROE: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 178
TABLE 222 ROE: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION) 178
TABLE 223 ROE: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 178
TABLE 224 ROE: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 179
TABLE 225 ROE: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 179
TABLE 226 ROE: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 179
TABLE 227 ROE: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 180

ページTOPに戻る

Table of Contents

Summary

The global western blotting market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.7% during the forecast period. Technological advancements, increasing government funding in the field of biomedical research, growing demand for personalized medicine, and the rising prevalence of HIV are the key factors driving the market growth.

“By instruments segment, the imagers sub segment accounted for the fastest-growing segment of the western blotting market”
Based on instruments, the western blotting market is segmented into gel electrophoresis instruments, blotting systems, and imagers. Growth in this product segment is primarily due to the automation of imagers, which simplifies the protein detection process.

“By end user segment, the academic & research institutes segment accounted for the largest share of the western blotting market”
Based on end users, the western blotting market is segmented into academic & research institutes, biopharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, and other end users In 2020, academic & research institutes accounted for the largest share of the western blotting market. The large share of the academic & research institutes end-user segment can be attributed to growing government investments for research activities and increasing research in the area of proteomics.

“Asia Pacific: The fastest-growing region in the western blotting market.”
The western blotting market in the Asia Pacific region is projected to register the highest growth during the forecast period. The major factors driving the growth of the Asia Pacific market include strong government support for the growth of the pharmaceutical and biotechnology industry, the presence of bioclusters in China and India, increasing funding for life science research, and growing initiatives related to target disease diagnosis.

“North America: the largest share of the western blotting market”
In 2020, North America accounted for the largest share of the western blotting market. The major factors driving the growth of this regional market include the presence of top manufacturers of western blotting products in this region, rise in research funding, increasing investments in proteomics research, and growing focus on personalized medicine.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

• By Respondent– Supply Side- 70%, Demand Side-30%
• By Designation— CXOs and Directors- 30%, Executives - 25%, Mangers - 45%
• By Region— North America - 40%, Europe - 25%, APAC – 20%, LATAM- 10% , MEA- 5%

Prominent players in the western blotting market include Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Bio-Techne Corporation (US), PerkinElmer, Inc. (US), LI-COR, Inc. (US), Advansta Inc. (US), Cell Signaling Technology, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Azure Biosystems, Inc. (US), Boster Biological Technology (US), Geno Technology Inc. (US), Rockland Immunochemicals, Inc. (US), Precision Biosystems (US), Cleaver Scientific Ltd. (UK), Abcam Plc (UK), Proteintech Group (US), Enzo Biochem, Inc. (US), Abnova Corporation (Taiwan), Sino Biological Inc. (China), StressMarq Biosciences Inc. (Canada), Abbexa Ltd. (UK), Covalab S.A.S. (France), and Biorbyt Ltd. (UK).

Research Coverage:
The report segments the western blotting market based on region (the Asia Pacific, Europe, North America, Latin America, and the Middle East & Africa), product (consumables [Reagents & Buffers, Antibodies & Conjugates {Primary Antibodies, Secondary Antibodies, Other Antibodies & Conjugates}, Kits
Membranes & Filter Papers Other Consumables], instruments [Electrophoresis, Blotting Systems {Semi-dry Blotting Systems, Wet Blotting Systems}, Imagers {Chemiluminescent Imagers, Fluorescent Imagers, Other Imagers}]), application (Biomedical Research, Clinical Diagnostics [HIV, Lyme Disease, Hepatitis, Other Diseases], Agricultural Applications, Other Applications), and end-user (Academic & Research Institutes, Biopharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Other End Users). The report also provides a comprehensive review of market drivers, restraints opportunities, challenges and trends in the western blotting market.

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the western blotting market and provides them information on key market drivers, restraints, challenges, and opportunities.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（抗生物薬）の最新刊レポート

MarketsandMarkets社の抗生物薬分野での最新刊レポート

本レポートと同じKEY WORD（antibody）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（抗生物薬）の最新刊レポート

MarketsandMarkets社の抗生物薬分野での最新刊レポート

本レポートと同じKEY WORD（antibody）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?